Navigation Links
InfraReDx Awarded 2010 Tax Incentive From Massachusetts Life Sciences Center
Date:12/23/2010

BURLINGTON, Mass., Dec. 23, 2010 /PRNewswire/ -- InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has been selected to receive an award of nearly $862,000 as part of the Massachusetts Life Sciences Center (MLSC) Tax Incentive Program. In conjunction with the award, InfraReDx has committed to create 32 new jobs during 2011.  

The Life Sciences Tax Incentive Program was established in 2008 as part of the state's 10-year, $1 billion Life Sciences Initiative. The program authorizes up to $25 million in tax incentives each year to expand life sciences-related employment opportunities, promote health-related innovations, and stimulate research and development, manufacturing and commercialization in the life sciences. The primary goal of the program is to incentivize life sciences companies to create new long-term jobs in Massachusetts.

"We are very pleased to be a recipient of these incentive funds for the second year in a row," said James E. Muller, M.D., founder and chief executive officer of InfraReDx. "There is an excellent fit between the goals of the Massachusetts Life Sciences Center and the stage of development that InfraReDx has reached. The MLSC seeks to expand life sciences-related jobs in Massachusetts; InfraReDx is a medical device company that has thrived because of the life sciences expertise concentrated in Massachusetts. The company has developed the LipiScan™ IVUS combination coronary catheter that uses both light and sound (near-infrared spectroscopy and intra-coronary ultrasound) to identify the fatty plaques that cause complications during stenting and are associated with heart attacks occurring in the community. We continue to hire life science workers to build additional systems and catheters to satisfy the rapidly growing demand for the product coming from hospitals throughout the world."

This year, the MLSC has named a total of $23.9 million in tax incentives for 30 life sciences companies.  The companies receiving the awards – typically late-stage life science companies transitioning from research and development to commercialization and manufacturing – have committed to creating nearly 1,000 new jobs in the Commonwealth over the coming year.

About InfraReDx, Inc.InfraReDx, Inc. is a privately funded medical device company improving patient care through the development and commercialization of intelligent imaging technologies to improve the diagnosis and treatment of coronary artery disease. InfraReDx's LipiScan™ IVUS Coronary Imaging System is the first and only available catheter to combine both near-infrared spectroscopy (NIR) and intravascular ultrasound (IVUS) technologies to both visualize and characterize the intracoronary lipid core plaques (LCP) suspected of causing the majority of heart attacks. Founded in 1998, InfraReDx is headquartered in Burlington, Massachusetts. For more information, visit www.infraredx.com.  Contacts:Susan Heins (media)Pure Communications, Inc. 864-286-9597sjheins@purecommunicationsinc.com Grant FrazierVice President of MarketingInfraReDx, Inc.781-345-9632gfrazier@infraredx.com
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan™ Coronary Imaging System
2. InfraReDx to Present at Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference
3. InfraReDx Announces Presentation of LipiScan™ Research at American Heart Association Scientific Sessions 2010
4. InfraReDx Completes $21 Million Equity Financing
5. InfraReDxs New LipiScan™ IVUS Coronary Imaging System to be Highlighted at TCT 2010
6. InfraReDxs LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology
7. InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundations (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting
8. First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
9. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
10. Pepex™ Awarded Qualifying Therapeutic Discovery Project Grant
11. Samplifys AutoFocus™ Beamforming Technology Awarded Electronic Designs Best of 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... SAN FRANCISCO , May 2, 2016 /PRNewswire/ ...  is expected to reach USD 11.1 billion by ... Grand View Research, Inc. Major drivers of the ... in therapeutic areas and government recommendations for periodic ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/29/2016)... PARIS , April 29, 2016 ... Jérôme Contamine, Directeur Financier ... la santé, publie ses résultats pour ... Financier du Groupe, Jérôme Contamine, commente ... Groupe et les perspectives pour le ...
Breaking Medicine Technology:
(Date:5/3/2016)... Aliso Viejo, CA (PRWEB) , ... May 03, 2016 , ... ... use in Final Cut Pro X. Pixel Film Studios’ titles allow users to add ... animations and basic elements such as boxes, lines and accents. To add greater contrast, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Today at its Annual Technology ... D. Pulido, R.Ph., Co-Founder of NCPDP and member of the NCPDP Foundation Board ... IT Specialist, Office of the National Coordinator for Health Information Technology (ONC). NCPDP’s ...
(Date:5/3/2016)... ... ... For over 23 years, Doctors on Liens has committed to ... and therapists treating personal injury patients on a lien basis. With the recent addition ... in Santa Monica, Doctors on Liens is continuing that tradition. While the network ...
(Date:5/3/2016)... ... ... With the opioid epidemic now at the forefront, attention has shifted away from ... its misuse causes long-term consequences for all aspects of society, from the disastrous effects ... and older. In addition, there is the long term affects of chronic liver ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... today announced that it has been honored as one of the nation’s most ... 2016 InformationWeek Elite 100. Horizon received the recognition for technology achievements that have ...
Breaking Medicine News(10 mins):